Pamela Esposito - Jul 15, 2021 Form 4 Insider Report for Replimune Group, Inc. (REPL)

Role: Chief Business Officer
Signature: /s/ Jean Franchi, attorney-in-fact
Stock symbol: REPL
Transactions as of: Jul 15, 2021
Transactions value $: -$148,856
Form type: 4
Date filed: 7/19/2021, 09:02 PM
Previous filing: Jun 17, 2021
Next filing: Jul 22, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	REPL	Common Stock	Options Exercise	$4.65K	+4.6K	+2.19%	$1.01^*	215K	Jul 15, 2021	Direct
transaction	REPL	Common Stock	Sale	-$154K	-4.6K	-2.14%	$33.37	210K	Jul 15, 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	REPL	Employee Stock Option (right to buy)	Options Exercise	$0	-4.6K	-6.28%	$0.00	68.6K	Jul 15, 2021	Common Stock	4.6K	$1.01	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on December 14, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.
F2	Following the sales reported on this Form 4, the reporting person continues to beneficially own 210,159 shares of the Issuer's common stock. The reporting person also holds options to acquire an aggregate of 544,267 shares of the Issuer's common stock, 345,191 of which are exercisable as of the date hereof.
F3	The reporting person was granted an option to purchase 149,203 shares of the Issuer's common stock on November 1, 2015. All of the shares underlying such stock option have vested and are exercisable as of the date hereof.